<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04290286</url>
  </required_header>
  <id_info>
    <org_study_id>i2TransHealth</org_study_id>
    <nct_id>NCT04290286</nct_id>
  </id_info>
  <brief_title>Interdisciplinary, Web-based Trans Health Care / i2TransHealth / Randomized Control Trial</brief_title>
  <official_title>Interdisciplinary, Web-based Trans Health Care / i2TransHealth / Randomized Control Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitätsklinikum Hamburg-Eppendorf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitätsklinikum Hamburg-Eppendorf</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      i2TransHealth is a randomized controlled trial that investigates the outcomes of a web-based
      healthcare approach for trans persons. As a health services research project, i2TransHealth
      aims at reducing the structural disadvantage for trans persons [people with transsexualism
      (TS: ICD-10), gender incongruence (GIC: ICD-11) and/or gender dysphoria (GD: DSM-5)] living
      in areas lacking specialized transition-related treatment.

      Located at the Institute for Sex Research and Sexual Medicine and in cooperation with the
      Interdisciplinary Transgender Health Care Center Hamburg (ITHCCH), both University Medical
      Center Hamburg-Eppendorf (UKE), i2TransHealth is an innovative intervention including video
      consultation and a 1:1 chat with clinical psychologists. By cooperating with the ITHCCH,
      general physicians and psychiatrists provide first and local access to the specialized
      treatment provided by the UKE.

      In the intervention group, the study participants are invited to use the i2TransHealth
      e-health platform including a video consultation hour every two weeks and a messenger between
      the video-meetings. In addition, they have the opportunity to receive medical support close
      to their home by licensed GPs and psychiatrists according to their needs (especially in case
      of a somatic or psychosocial crisis). The waiting group participants will be able to go
      forward with transition-related care after four months of study participation, either via the
      i2TransHealth e-health approach or as part of standard care.

      The primary outcome measure is a reduced symptomatology for trans persons (BSCL). Secondary
      outcome parameters include quality of life and patient satisfaction as well as
      healthcare-related costs and cost-effectiveness. Finally, based on a longitudinal design, it
      will be assessed if the physicians improve their trans-related expertise by cooperating
      within the i2TransHealth-network.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Symptom burden according to BSI-18</measure>
    <time_frame>Change from Baseline Mental Health Symptoms to the point of time after online intervention (Baseline + 4 months)</time_frame>
    <description>References:
Franke, G. H. (2000). Franke, G.H. (2000). BSI. Brief Symptom Inventory - Deutsche Version. Manual. Göttingen: Beltz.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of Life (physical health, psychological health, social relationships, and environment)</measure>
    <time_frame>Change from Baseline QoL to the point of time after online intervention (Baseline + 4 months)]</time_frame>
    <description>QoL is measured using the WHOQOL-BREF (WHO, 1998).
References:
Angermeyer, M. C., Kilian, R., &amp; Matschinger, H. (2000). WHOQOL - WHOQOL-100 und WHOQOL-BREF. Handbuch für die deutschsprachigen Versionen der WHO Instrumente zur Erfassung von Lebensqualität.
WHO (1998). Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychological medicine, 28(3), 551-558.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment satisfaction according to modified version ZUF-8</measure>
    <time_frame>Treatment satisfaction at the point of time after online intervention (4 months after admission to studies)</time_frame>
    <description>References:
Schmidt, J., Lamprecht, F., &amp; Wittmann, W. W. (1989). Zufriedenheit mit der stationären Versorgung. Entwicklung eines Fragebogens und erste Validitätsuntersuchungen. [Satisfaction with inpatient care: Development of a questionnaire and first validity assessments.]. PPmP: Psychotherapie Psychosomatik Medizinische Psychologie, 39(7), 248-255.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Direct or indirect costs and productivity losses by persons with TS/GD in comparison to the German general population (via CSSRI)</measure>
    <time_frame>Change from Baseline to the point of time after online intervention (Baseline + 4 months)</time_frame>
    <description>References:
Chisholm, D., Knapp, M. R. J., Knudsen, H. C., Amaddeo, F., Gaite, L., Wijngaarden, B. van, &amp; Group, E. S. (2000). Client Socio-Demographic and Service Receipt Inventory - European Version: Development of an instrument for international research: EPSILON Study 5. The British Journal of Psychiatry, 177(S39), s28-s33. https://doi.org/10.1192/bjp.177.39.s28</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health-related quality of life (via EQ-5D-5L): quality-adjusted life years (QALYs)</measure>
    <time_frame>Change from Baseline to the point of time after online intervention (Baseline + 4 months)</time_frame>
    <description>References:
Herdman, M., Gudex, C., Lloyd, A., Janssen, MF., Kind, P., Parkin, D., … Badia, X. (2011). Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Quality of Life Research, 20(10), 1727-1736. https://doi.org/10.1007/s11136-011-9903-x</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Knowledge increase of the cooperating physicians on trans health care (via VSE)</measure>
    <time_frame>Change from Baseline to the point of time after study completion (Baseline + 18 months)</time_frame>
    <description>References:
Raupach, T., Schiekirka, S., Münscher, C., Beißbarth, T., Himmel, W., Burckhardt, G., &amp; Pukrop, T. (2012). Implementierung und Erprobung eines Lernziel-basierten Evaluationssystems im Studium der Humanmedizin. GMS Zeitschrift für medizinische Ausbildung, 29(3), 1-14.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction of the cooperating physicians with the support in the i2TransHealth network (via modified version ZUF-8)</measure>
    <time_frame>Satisfaction at the point of time after study completion (18 months)</time_frame>
    <description>References:
Schmidt, J., Lamprecht, F., &amp; Wittmann, W. W. (1989). Zufriedenheit mit der stationären Versorgung. Entwicklung eines Fragebogens und erste Validitätsuntersuchungen. [Satisfaction with inpatient care: Development of a questionnaire and first validity assessments.]. PPmP: Psychotherapie Psychosomatik Medizinische Psychologie, 39(7), 248-255.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">210</enrollment>
  <condition>Gender Dysphoria</condition>
  <condition>Gender Identity Disorder</condition>
  <condition>Transsexualism</condition>
  <condition>Gender Identity</condition>
  <condition>Gender Incongruence</condition>
  <arm_group>
    <arm_group_label>intervention group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Trans persons (n = 105) receive 4 months of e-health intervention according to the i2TransHealth model of care (intervention group)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>waiting group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Trans persons (n = 105) wait 4 months until they are offered online intervention according to the i2TransHealth model of care (waiting group)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>i2TransHealth</intervention_name>
    <description>i2TransHealth: online intervention for trans persons</description>
    <arm_group_label>intervention group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 years or older

          -  Gender different from their assigned sex at birth

          -  resident at least 50 km outside Hamburg

          -  present themselves with treatment needs (TS/GD) to one of the participating physicians
             in the i2TransHealth network, or direct contact with institute and/or e-health
             platform

          -  receive the suspected diagnosis TS/GD during an initial interview in the UKE

          -  can operate the video chat cognitively, verbally and auditory

          -  Able to read, speak, and understand German

          -  Written informed consent after written and oral information

        Exclusion Criteria:

          -  Under 18 years of age

          -  Missing informed consent

          -  Unable to speak German

          -  Indication for inpatient treatment, e.g. due to acute psychotic symptoms (self-report,
             Prodromal Questionnaire, PQ-B) or severe depressive symptoms (self-report, BDI-II ≥
             29)

          -  Acute suicidal tendencies

          -  Decrease in intelligence (IQ below 70)

          -  Acute drug intoxication

          -  Failure to meet technical requirements (no Internet access, lack of IT knowledge)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Timo Nieder, PhD ECPS</last_name>
    <phone>+4940 7410 52226</phone>
    <email>t.nieder@uke.de</email>
  </overall_contact>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 26, 2020</study_first_submitted>
  <study_first_submitted_qc>February 26, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 28, 2020</study_first_posted>
  <last_update_submitted>February 26, 2020</last_update_submitted>
  <last_update_submitted_qc>February 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitätsklinikum Hamburg-Eppendorf</investigator_affiliation>
    <investigator_full_name>Timo Nieder</investigator_full_name>
    <investigator_title>Timo Nieder, PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gender Dysphoria</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

